People living with HIV who inject or have injected non-prescription drugs: Evidence of substantial differences in health inequalities and experiences of clinical care.

INTRODUCTION This study investigates differences in health and well-being associated with current, past or no injecting drug use (IDU) among people living with HIV (PLHIV) in Australia, identifying key health care considerations between injecting experiences. METHODS Data were extracted from the HIV Futures 9 study; a survey of PLHIV conducted in 2018-2019. Chi-square and analysis of variance analyses compared clinical and treatment characteristics, major physical and mental comorbidities, sexually transmitted infection diagnoses, and quality of life for those who reported current (last 12 months), past (12+ months ago) or no IDU. RESULTS Current IDU (n = 106) was associated with higher rates of sexually transmitted infection testing and diagnoses, higher frequency of self-reported antiretroviral therapy non-adherence due to drug use and greater social quality of life than past (n = 126) or no IDU (n = 508; total N = 740). Past and current IDUs were associated with more mental illness diagnoses and self-reported concern about drug use. Past IDU was associated with more physical comorbidities, lower satisfaction with clinical care and greater difficulty in affording health care than current or no IDU. DISCUSSION AND CONCLUSIONS Past and current IDUs are associated with unique health concerns. However, past IDU appears to be related to greater dissatisfaction in navigating health care than individuals with current IDU experience. Higher social connection and the types of services being accessed by individuals who currently inject may play a role in shaping service satisfaction. Peer-based interventions to help support individuals in accessing services that are affirming of their needs is an ongoing priority.

[1]  G. Melendez‐Torres,et al.  Health literacy, financial insecurity and health outcomes among people living with HIV in Australia. , 2022, Health promotion international.

[2]  Robert W. S. Coulter,et al.  Impact of harm reduction care in HIV clinical settings on stigma and health outcomes for people with HIV who use drugs: study protocol for a mixed-methods, multisite, observational study , 2022, BMJ Open.

[3]  G. Prestage,et al.  Individual level peer interventions for gay and bisexual men who have sex with men between 2000 and 2020: A scoping review , 2022, PloS one.

[4]  A. Pedrana,et al.  "It's not just the hit itself": the social practice of injecting drug use among gay and bisexual men in Australia. , 2022, The International journal on drug policy.

[5]  R. Berg,et al.  The effectiveness of peer-support for people living with HIV: A systematic review and meta-analysis , 2021, PloS one.

[6]  P. Aggleton,et al.  Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex. , 2021, The International journal on drug policy.

[7]  P. Saberi,et al.  The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. , 2020, AIDS research and human retroviruses.

[8]  M. Noroozi,et al.  Methamphetamine use and HIV risk behavior among men who inject drugs: causal inference using coarsened exact matching , 2020, Harm Reduction Journal.

[9]  D. Ompad,et al.  “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City , 2020, Harm Reduction Journal.

[10]  L. Degenhardt,et al.  Characteristics of gay and bisexual men who rarely use HIV risk reduction strategies during condomless anal intercourse: Results from the FLUX national online cohort study , 2020, PloS one.

[11]  L. Degenhardt,et al.  Biomedical HIV Protection Among Gay and Bisexual Men Who Use Crystal Methamphetamine , 2019, AIDS and Behavior.

[12]  Dan J Stein,et al.  The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys. , 2019, The International journal on drug policy.

[13]  Y. Hao,et al.  Peer education for HIV prevention among high-risk groups: a systematic review and meta-analysis , 2019, BMC Infectious Diseases.

[14]  M. Hellard,et al.  Hepatitis C risk perceptions and attitudes towards reinfection among HIV‐diagnosed gay and bisexual men in Melbourne, Australia , 2019, Journal of the International AIDS Society.

[15]  L. Degenhardt,et al.  Mental health, drug use and sexual risk behavior among gay and bisexual men. , 2018, The International journal on drug policy.

[16]  L. Degenhardt,et al.  Prevalence and correlates of recent injecting drug use among gay and bisexual men in Australia: Results from the FLUX study. , 2018, The International journal on drug policy.

[17]  A. Lyons,et al.  Development and validation of PozQoL: a scale to assess quality of life of PLHIV , 2018, BMC Public Health.

[18]  P. Aggleton,et al.  The rush to risk when interrogating the relationship between methamphetamine use and sexual practice among gay and bisexual men. , 2017, The International journal on drug policy.

[19]  P. Weatherburn,et al.  Substance use among men who have sex with men: patterns, motivations, impacts and intervention development need , 2017, Sexually Transmitted Infections.

[20]  G. Dowsett,et al.  HIV Futures 8: Protocol for a Repeated Cross-sectional and Longitudinal Survey of People Living with HIV in Australia , 2017, Front. Public Health.

[21]  A. Schmidt,et al.  Illicit drug use among gay and bisexual men in 44 cities: Findings from the European MSM Internet Survey (EMIS). , 2016, The International journal on drug policy.

[22]  J. D. de Wit,et al.  Methamphetamine use among gay and bisexual men in Australia: Trends in recent and regular use from the Gay Community Periodic Surveys. , 2016, The International journal on drug policy.

[23]  A. Lyons,et al.  HIV and Elevated Mental Health Problems: Diagnostic, Treatment, and Risk Patterns for Symptoms of Depression, Anxiety, and Stress in a National Community-Based Cohort of Gay Men Living with HIV , 2016, AIDS and Behavior.

[24]  P. Havinga,et al.  Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands , 2014, Harm Reduction Journal.

[25]  M. Hellard,et al.  Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. , 2014, International journal of epidemiology.

[26]  E. Brouwers,et al.  Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. , 2013, Drug and alcohol dependence.

[27]  C. Beyrer,et al.  The changing epidemiology of HIV in 2013 , 2013, Current opinion in HIV and AIDS.

[28]  Rachel A. Smith,et al.  A meta-analysis of disclosure of one's HIV-positive status, stigma and social support , 2008, AIDS care.

[29]  D. Kanouse,et al.  Perceived discrimination in clinical care in a nationally representative sample of HIV-infected adults receiving health care , 2005, Journal of General Internal Medicine.

[30]  I. Meyer.  Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence. , 2003, Psychological bulletin.

[31]  Yongxu Huang,et al.  Patterns and levels of illicit drug use among men who have sex with men in Asia. , 2012, Drug and alcohol dependence.

[32]  Non-prescription drug use among HIV positive gay and bisexual men in Australia: A latent class analysis and comparison of health and well-being , 2022, International Journal of Drug Policy.